Beta-blockers in the prevention of myocardial infarction.
作者信息
Hampton J R
出版信息
Practitioner. 1984 Jan;228(1387):55-63.
PMID:6141556
Abstract
摘要
相似文献
1
Beta-blockers in the prevention of myocardial infarction.β受体阻滞剂在预防心肌梗死中的应用
Practitioner. 1984 Jan;228(1387):55-63.
2
[Beta-blockers and secondary prevention after myocardial infarction].[心肌梗死后的β受体阻滞剂与二级预防]
Therapie. 1984 Mar-Apr;39(2):189-96.
3
[Secondary prevention of myocardial infarct using beta-blockers].[使用β受体阻滞剂进行心肌梗死的二级预防]
Bull Acad Natl Med. 1985 Mar;169(3):369-73.
4
Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
Pharmatherapeutica. 1984;3(8):515-25.
5
Secondary prevention after myocardial infarction: facts and fallacies.
J Cardiovasc Pharmacol. 1984;6 Suppl 6:S914-21.
6
Reduction in cardiac death and reinfarction rates caused by beta-blockers after acute myocardial infarction.
Kardiol Pol. 1983;26(4):281-6.
7
[Use of beta-blockers in the secondary prevention of acute myocardial infarcts. Status and recomendations].
Ugeskr Laeger. 1984 Mar 19;146(12):863-8.
8
[Value of beta-blockers in the long-term prevention of morbidity and mortality after myocardial infarction].
Coeur Med Interne. 1980 Jan-Mar;19(1):61-5.
9
[Beta receptor blockers in acute myocardial infarct and in secondary prevention].[β受体阻滞剂在急性心肌梗死及二级预防中的应用]
Internist (Berl). 1991 Jun;32(6):359-60.
10
The role of pharmacotherapy in secondary prevention of myocardial infarction and death.
Mt Sinai J Med. 1984 Jun;51(3):229-36.
引用本文的文献
1
Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.美托洛尔。对其药效学和药代动力学特性以及在高血压、缺血性心脏病和相关心血管疾病中的治疗效果的最新综述。
Drugs. 1986 May;31(5):376-429. doi: 10.2165/00003495-198631050-00002.
Zotero 插件